Testing effectiveness (Phase 2)UnknownNCT05447013
What this trial is testing
Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients
Who this might be right for
Severe COVID-19
George Papanicolaou Hospital 182